$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Several things patients must know when taking the drug: What are the warnings and precautions for ivonib?
2026-02-01 22:25:32
Check Details
Comparison of the efficacy and safety of Ivosidenib and Venetoclax in the treatment of intermediate-stage acute myeloid leukemia
2026-02-01 22:25:32
Check Details
New hope in the fight against cancer: Can Ivonib cure cancer?
2026-02-01 22:25:32
Check Details
The latest directive from medical insurance: Avonib can be included in medical insurance
2026-02-01 22:25:32
Check Details
What is the latest price of domestically produced Avonib in 2024?
2026-02-01 22:25:32
Check Details
Latest purchase details: Is Avonib available in China?
2026-02-01 22:25:32
Check Details
Is there a generic version of ivonib?
2026-02-01 22:25:32
Check Details
Detailed explanation of the efficacy and role of ivonib
2026-02-01 22:25:32
Check Details
Cancer specific drug: What are the indications for ivonib?
2026-02-01 22:25:32
Check Details
Latest price situation: How much does it cost to import Avonib?
2026-02-01 22:25:32
Check Details
One thing patients must know: Are the side effects of ivonib serious?
2026-02-01 22:25:32
Check Details
What kind of targeted drug is ivonib used to treat and how to take it?
2026-02-01 22:25:32
Check Details
1
2
...
476
477
478
479
480
481
482
...
10222
10223
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Elagolix Side Effects and Safety Guide
2
Hetrombopag vs. Avatrombopag: Key Differences Between Two Oral TPO-RAs and Safety Considerations
3
Lytenava: The First FDA-Approved Ophthalmic Bevacizumab Formulation
4
FDA Approves Lytenava: First Ophthalmic Bevacizumab for Wet AMD
5
Simtriyo (Centanafadine): World's First NDSRI ADHD Drug Approved by FDA
6
Lipfendra (Enlicitide): The World's First Oral PCSK9 Inhibitor Approved by FDA
7
Orforglipron: The World's First Oral Small-Molecule GLP-1 Receptor Agonist for Weight Management
8
Cabozantinib Capsules: A Multi-Targeted Therapy for Progressive Medullary Thyroid Cancer
9
Lorlatinib: Mechanism, Advantages, and Key Considerations of Third-Generation ALK Inhibitor Therapy in ALK-Positive NSCLC
10
FDA Approves Subcutaneous Isatuximab (Sarclisa) for Multiple Myeloma: A New Administration Option
11
Pemigatinib Side Effects Explained: Managing Adverse Reactions of FGFR-Targeted Therapy in Cholangiocarcinoma
12
Selpercatinib: Before or After Meals? A Complete Guide to RET-Targeted Therapy Administration